Cultured human myocardial fibroblasts of pediatric origin: Natural human interferon-α is more effective than recombinant interferon-α 2a in carrier-state coxsackievirus B3 replication

This publication has 31 references indexed in Scilit:

• Enterovirus‐induced myocarditis: Hemodynamic deterioration with immunosuppressive therapy and successful application of interferon‐α
  Clinical Cardiology, 1994
• Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction
  American Heart Journal, 1993
• Synergistic Interaction of Interferon- and Interferon- in Coxsackievirus B3-Infected Carrier Cultures of Human Myocardial Fibroblasts
  The Journal of Infectious Diseases, 1992
• Evolving concepts of cause, consequence, and control in myocarditis
  Current Opinion in Cardiology, 1991
• Clinical Pharmacokinetics of Interferons
  Clinical Pharmacokinetics, 1990
• Reversible Cardiac Dysfunction Associated with Interferon Alfa Therapy in AIDS Patients with Kaposi's Sarcoma
  New England Journal of Medicine, 1989
• Outcome in children with enteroviral meningitis during the first year of life
  The Journal of Pediatrics, 1987
• DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHY
  The Lancet, 1986
• Seventy-five years of cardiac tissue and cell culture
  Trends in Pharmacological Sciences, 1985
• Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon
  Journal of Molecular and Cellular Cardiology, 1985